Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001178913-24-003893
Filing Date
2024-12-02
Accepted
2024-12-02 16:22:12
Documents
7

Document Format Files

Seq Description Document Type Size
1 POS AM zk2432420.htm POS AM 307809
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 9935
3 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 2236
4 FILING FEES TABLE exhibit_107.htm EX-FILING FEES 24630
5 image00003.jpg GRAPHIC 4970
6 image00004.jpg GRAPHIC 377003
7 image00005.jpg GRAPHIC 175385
  Complete submission text file 0001178913-24-003893.txt   1113574
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-255249 | Film No.: 241519352
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)